Hypnotika - Stand der Forschung

Nissen, C. and Frase, L. and Hajak, G. and Wetter, T. C. (2014) Hypnotika - Stand der Forschung. NERVENARZT, 85 (1). pp. 67-76. ISSN 0028-2804, 1433-0407

Full text not available from this repository. (Request a copy)

Abstract

This article provides an overview of the indications and effects of sleep-inducing drugs. Pharmacological treatment should only be considered in cases of insufficient response to non-pharmacological interventions. Benzodiazepines and benzodiazepine receptor agonists are indicated for the short-term treatment of acute insomnia. Due to the risk of tolerance and dependency, sedative antihistamines and antidepressants are widely used as long-term hypnotics. Other substances, including herbal compounds and melatonin have few side effects; however, the therapeutic efficacy is very limited. Currently, longterm data on the efficacy and tolerability of sleep-inducing substances are lacking. Specifically in cases of non-response to first line treatment, extended psychiatric and somatic evaluation and treatment of associated disorders are recommended.

Item Type: Article
Uncontrolled Keywords: PRIMARY INSOMNIA; DOUBLE-BLIND; SLEEP; DOXEPIN; ABUSE; Sleep; Insomnia; Soporifics; Hypnotics; Benzodiazepines
Subjects: 100 Philosophy & psychology > 150 Psychology
Divisions: Medicine > Lehrstuhl für Psychiatrie und Psychotherapie
Depositing User: Dr. Gernot Deinzer
Date Deposited: 29 Nov 2019 11:39
Last Modified: 29 Nov 2019 11:39
URI: https://pred.uni-regensburg.de/id/eprint/11044

Actions (login required)

View Item View Item